SuRo Capital Corp (SSSS) Reports Wider Loss Q4 EPS Estimates by 10.0%
**SuRo Capital Corp Reports Wider-Than-Expected Q4 Loss**
Breaking news, market updates, and exclusive interviews
**SuRo Capital Corp Reports Wider-Than-Expected Q4 Loss**
**Tenax Therapeutics Reports Q4 2025 Results**
Bloom Energy posts GAAP EPS beat at $0.45 vs $0.30 estimate, but adjusted EPS...
Gregory T. Lucier purchased 15,000 shares at $12.445, deploying $186,675 to increase his stake...
URBN executives forfeited 30,862 shares worth $2.03M for tax withholding on March 9, led...
SCI President forfeited 3,300 shares at $81.42 for tax obligations, part of a four-executive...
TL;DR: Washington is tightening the screws on tech M&A, and the message from regulators is clear: the era of Big...
Dr. Shalabh Gupta, CEO of Unicycive Therapeutics, discusses the company’s focus on kidney care and its lead drug candidate for...